SANUWAVE Health, Inc. (SNWV)

Market Cap	350.43M
Revenue (ttm)	39.19M
Net Income (ttm)	-38.03M
Shares Out	8.57M
EPS (ttm)	-5.30
PE Ratio	n/a
Forward PE	85.21
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,217
Open	40.90
Previous Close	41.70
Day's Range	40.90 - 40.90
52-Week Range	5.21 - 46.59
Beta	1.29
Analysts	Strong Buy
Price Target	49.00 (+19.8%)
Earnings Date	Aug 7, 2025

About SNWV

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and ch...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 46
• Stock Exchange: NASDAQ
• Ticker Symbol: SNWV
• Website: https://sanuwave.com

Financial Performance

In 2024, SANUWAVE Health's revenue was $32.63 million, an increase of 59.99% compared to the previous year's $20.40 million. Losses were -$31.37 million, 21.6% more than in 2023.

Analyst Forecast

According to one analyst, the rating for SNWV stock is "Strong Buy" and the 12-month stock price target is $49.0.

Price Target

$49.0

(19.80% upside)

Analyst Consensus: Strong Buy